What data says about Tukaram Mundhe’s 100-day stint as FDA Commissioner
The story in brief
The FDA presented data showing a 121% rise in FIRs and a 234% increase in searches and seizures against drug manufacturers and sellers in the last three months. Regulatory actions per month rose from 258 to 293, with Ayurvedic inspections reaching 301. The agency emphasized a dramatic increase in enforcement metrics compared to the previous five years.